| 10:00 12:00 Ambulatory: The Practice of Pediatric Cardiology | |
|---|---|
| 10:00 10:20 | Neurodevelopmental clinics: Who needs to go, when, and what is in it for my child? |
| 10:20 10:40 | Common pediatric problems still occur in children with CHD: Immunizations & noncardiac surgery |
| 10:40 11:00 | Etiology of and treatment of essential hypertension |
| 11:00 11:20 | Anticoagulation in heart disease in children and adolescents |
| 11:20 11:40 | Smoking, passive smoke and e-cigarettes |
| 11:40 12:00 | Discussion |
| 13:30 15:30 Ambulatory: When to Worry? | |
|---|---|
| 13:30 13:50 | Drugs that effect the QT, why does this happen and when to worry? |
| 13:50 14:10 | Liberalizing exercise restrictions and safety letting them play |
| 14:10 14:30 | PVCs in the structurally normal heart: what workup is needed so I do not worry? |
| 14:30 14:50 | Congenital Heart Disease Screening: Is Pulse Oximetry Enough |
| 14:50 15:10 | Is that LVH or HCM in my athletic patient? |
| 10:00 12:00 Ambulatory & Genetics: Genetics/Genomics for the Practicing Cardiologist | |
|---|---|
| 10:00 10:20 | Genetics 101 How Do You Spell D-N-A? |
| 10:20 10:40 | Genetic Testing in Pediatric Cardiology |
| 10:40 11:00 | Pharmacogenetics 101 GATCs, CYPs, VKORCs |
| 11:00 - 11:20 | Mutation Calling: What goes into elevating a variant to "The Disease Calling Mutation? |
| 11:20 11:40 | Five Reasons NOT to Order a Genetic Test! |
| 11:40 12:00 | Discussion |
| 13:30 15:30 Coronary: Congenital Coronary Artery Disease | |
|---|---|
| 13:30 13:50 | Anatomic assessment of coronary arteries: Current imaging strategies and diagnostic testing for coronary artery anatomy and perfusion in children. |
| 13:50 14:10 | Functional assessment of coronary arteries |
| 14:10 14:30 | An international perspective of anomalous origin of the coronary arteries: Review of existing guidelines |
| 14:30 14:50 | Coronary artery fistulae: When to Worry and What to Do? |
| 14:50 15:10 | Anomalous Coronary Artery from the Pulmonary Artery: Case Reviews of Typical & Atypical Presentations. |
| 15:10 15:30 | Surgical options for anomalous origin of the coronary arteries. |
| 13:30 15:30 Ambulatory: Abstracts and plenary speaker | |
|---|---|
| 13:30 14:45 | Top 5 Ambulatory Abstracts |
| 14:45 15:30 | Plenary Lecture: "Lifetime Management of CV Risk: Investing in Your Arteries |
| 13:30 15:30 ACC Quality Metrics: Quality Improvement in CHD at ACC | |
|---|---|
| 13:30 13:50 | Cardiac Catheterization (IMPACT Registry/RRR) |
| 13:50 14:10 | Congenital Heart Programs Q Net |
| 14:10 14:30 | NPC QIC |
| 14:30 14:50 | Transparency Efforts |
| 14:50 15:30 | Discussion |
| 10:00 12:00 Ambulatory: Obesity in Childhood | |
|---|---|
| 10:00 10:20 | Worldwide prevalence and pattern of childhood obesity |
| 10:20 10:40 | Cardiometabolic consequences of obesity in the young |
| 10:40 11:00 | Genetics, epigenetics and early environment on obesity and cardiovascular consequences |
| 11:00 11:20 | Can childhood obesity be managed in families? |
| 11:20 11:40 | Population strategies for childhood obesity: lessons from smoking |
| 11:40 -12:00 | Panel discussion |
| 13:30 15:30 Endocarditis-Pericarditis | |
|---|---|
| 13:30 13:50 | Management of chronic and constrictive pericarditis |
| 13:50 14:10 | Management of post-pericardiotomy syndrome |
| 14:10 14:30 | Early surgical therapy for bacterial endocarditis |
| 14:30 14:50 | Endocarditis in implantable devices (e.g. valves, VADs, pacemakers, etc.) |
| 14:50 15:10 | Endocardial Fibroelastosis |
| 15:10 15:30 | Discussion |
| 10:00 12:00 Ambulatory with PACHDA: Ambulatory Bridge Session with Pan-Arab Congenital Heart Disease Association (PACHDA) | |
|---|---|
| LV Outflow Tract Obstruction: from Fetal to Adult Life. | |
| 10:00 10:20 | Fetal Detection for LVOT Obstruction |
| 10:20 10:40 | Anatomical Variations of LV Outflow Tract |
| 10:40 11:00 | Echocardiographic Imaging of LVOT |
| 11:00 11:20 | Surgical Options for LVOT |
| 11:20 11:40 | Case Presentation |
| 11:40 12:00 | Panel Discussion |
| 13:30 15:30 Ambulatory: Controversies in Management of Dyslipidemia in Youth | |
|---|---|
| 13:30 13:50 | Childhood Obesity: A Lifetime of Endothelial Dysfunction Beyond North America |
| 13:50 14:10 | Familial hypercholesterolemia: the prevalence is higher than previously estimated utility of country-wide cascade screening |
| 14:10 14:30 | Treatment of dyslipidemia in young adults: How to reconcile the pediatric vs adult guidelines. |
| 14:30 14:50 | Universal screening for dyslipidemia in youth should be promoted |
| 14:50 15:10 | Selective screening is the best approach for screening for dyslipidemia in youth |
| 15:10 15:30 | Discussion |
| 13:30 15:30 Coronary: Acquired Coronary Artery Disease | |
|---|---|
| 13:30 13:50 | Acquired coronary artery disease in adolescents and young adults: Finding the needle in the haystack. |
| 13:50 14:10 | Coronary artery impairment early and late after cardiac surgery in children |
| 14:10 14:30 | Indications and outcomes of coronary artery stenting in children from post-op complications to transplant coronary artery disease |
| 14:30 14:50 | Acquired coronary artery disease in adult congenital heart disease |
| 14:50 15:10 | Acute management of Kawasaki disease to prevent coronary compromise |
| 15:10 15:30 | Mid- and Long-term management of coronary artery anomalies related to Kawasakis Disease |